Palasis Maria 4
4 · Lyra Therapeutics, Inc. · Filed Oct 3, 2025
Insider Transaction Report
Form 4
Palasis Maria
DirectorPresident & CEO
Transactions
- Award
Employee Stock Option (right to buy)
2025-10-01+3,667→ 7,333 totalExercise: $303.50Exp: 2034-03-20→ Common Stock (3,667 underlying)
Footnotes (1)
- [F1]On March 21, 2024, the Reporting Person was granted a performance stock option ("PSO") for an aggregate of up to 11,000 shares of common stock (or 550,000 shares on a pre-split basis) under the Issuer's 2020 Incentive Award Plan (the "Agreement"). Under the terms of the Agreement, the underlying PSO shares will vest upon certain milestone events. On October 1, 2025, the Issuer determined that Milestone 2 of the PSO was achieved, resulting in 3,667 PSOs being earned. The earned PSOs will vest on January 31, 2028.